Moreover, in contrast to CF patients, neither clinical exacerbation of IBD nor RA was associated with decreasing rates of circulating CCR6+ ILC2s (Figures 2F,G), indicating a distinct functional role of CCR6+ pb ILC2s in CF. The gene discussed is CCR6; the disease is inflammatory bowel disease.